US Stock MarketDetailed Quotes

ELYM Eliem Therapeutics

Watchlist

3.390
-0.270-7.38%

Close Apr 25 16:00 ET

3.400
+0.010+0.29%

Pre 08:00 ET

93.97MMarket Cap-2607P/E (TTM)

Eliem Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-10.77%40.28M

-46.39%5.12M

-42.83%5M

-51.00%6.71M

78.48%23.44M

26.53%45.14M

-10.74%9.55M

-6.77%8.75M

57.36%13.7M

90.90%13.13M

Selling and administrative expenses

31.41%24.86M

-56.88%2M

-52.67%2.13M

-38.65%3.03M

263.67%17.72M

53.21%18.92M

21.00%4.63M

32.29%4.49M

69.25%4.93M

119.66%4.87M

-General and administrative expense

31.41%24.86M

-56.88%2M

-52.67%2.13M

-38.65%3.03M

263.67%17.72M

53.21%18.92M

21.00%4.63M

32.29%4.49M

69.25%4.93M

119.66%4.87M

Research and development costs

-41.21%15.41M

-36.53%3.13M

-32.46%2.88M

-57.94%3.69M

-30.75%5.72M

12.40%26.21M

-28.38%4.93M

-28.90%4.26M

51.37%8.77M

77.22%8.26M

Operating profit

10.77%-40.28M

46.39%-5.12M

42.83%-5M

51.00%-6.71M

-78.48%-23.44M

-26.53%-45.14M

10.74%-9.55M

6.77%-8.75M

-57.36%-13.7M

-90.90%-13.13M

Net non-operating interest income expense

236.00%4.62M

77.50%1.35M

229.24%1.26M

1.38M

760K

383K

Non-operating interest income

236.00%4.62M

77.50%1.35M

229.24%1.26M

----

--1.38M

--760K

--383K

----

Other net income (expense)

136.12%536K

-87.21%132K

82.69%-228K

266.93%1.49M

1,694.44%1.15M

87.43%-1.48M

553.16%1.03M

-467.67%-1.32M

-7,358.33%-895K

99.39%-72K

Gain on sale of security

136.12%536K

-87.21%132K

82.69%-228K

136.85%384K

257.96%248K

-772.94%-1.48M

953.06%1.03M

-422.62%-1.32M

-8,583.33%-1.04M

-3,825.00%-157K

Other non- operating income (expenses)

----

655.10%1.11M

958.82%900K

----

--147K

100.73%85K

Income before tax

22.38%-35.12M

53.09%-3.64M

59.02%-3.97M

64.24%-5.22M

-68.81%-22.29M

4.71%-45.24M

26.39%-7.76M

-0.70%-9.68M

-67.40%-14.6M

29.01%-13.2M

Income tax

Net income

22.38%-35.12M

53.09%-3.64M

59.02%-3.97M

64.24%-5.22M

-68.81%-22.29M

4.71%-45.24M

26.39%-7.76M

-0.70%-9.68M

-67.40%-14.6M

29.01%-13.2M

Net income continuous Operations

22.38%-35.12M

53.09%-3.64M

59.02%-3.97M

64.24%-5.22M

-68.81%-22.29M

4.71%-45.24M

26.39%-7.76M

-0.70%-9.68M

-67.40%-14.6M

29.01%-13.2M

Minority interest income

Net income attributable to the parent company

22.38%-35.12M

53.09%-3.64M

59.02%-3.97M

64.24%-5.22M

-68.81%-22.29M

4.71%-45.24M

26.39%-7.76M

-0.70%-9.68M

-67.40%-14.6M

29.01%-13.2M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

22.38%-35.12M

53.09%-3.64M

59.02%-3.97M

64.24%-5.22M

-68.81%-22.29M

13.04%-45.24M

26.39%-7.76M

11.47%-9.68M

-34.40%-14.6M

32.93%-13.2M

Basic earnings per share

24.42%-1.3

55.17%-0.13

59.46%-0.15

66.07%-0.19

-68.00%-0.84

59.43%-1.72

27.50%-0.29

47.14%-0.37

-20.96%-0.56

70.38%-0.5

Diluted earnings per share

24.42%-1.3

55.17%-0.13

59.46%-0.15

66.07%-0.19

-68.00%-0.84

59.43%-1.72

27.50%-0.29

47.14%-0.37

-20.96%-0.56

70.38%-0.5

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-10.77%40.28M	-46.39%5.12M	-42.83%5M	-51.00%6.71M	78.48%23.44M	26.53%45.14M	-10.74%9.55M	-6.77%8.75M	57.36%13.7M	90.90%13.13M
Selling and administrative expenses	31.41%24.86M	-56.88%2M	-52.67%2.13M	-38.65%3.03M	263.67%17.72M	53.21%18.92M	21.00%4.63M	32.29%4.49M	69.25%4.93M	119.66%4.87M
-General and administrative expense	31.41%24.86M	-56.88%2M	-52.67%2.13M	-38.65%3.03M	263.67%17.72M	53.21%18.92M	21.00%4.63M	32.29%4.49M	69.25%4.93M	119.66%4.87M
Research and development costs	-41.21%15.41M	-36.53%3.13M	-32.46%2.88M	-57.94%3.69M	-30.75%5.72M	12.40%26.21M	-28.38%4.93M	-28.90%4.26M	51.37%8.77M	77.22%8.26M
Operating profit	10.77%-40.28M	46.39%-5.12M	42.83%-5M	51.00%-6.71M	-78.48%-23.44M	-26.53%-45.14M	10.74%-9.55M	6.77%-8.75M	-57.36%-13.7M	-90.90%-13.13M
Net non-operating interest income expense	236.00%4.62M	77.50%1.35M	229.24%1.26M			1.38M	760K	383K
Non-operating interest income	236.00%4.62M	77.50%1.35M	229.24%1.26M	----	----	--1.38M	--760K	--383K	----	----
Other net income (expense)	136.12%536K	-87.21%132K	82.69%-228K	266.93%1.49M	1,694.44%1.15M	87.43%-1.48M	553.16%1.03M	-467.67%-1.32M	-7,358.33%-895K	99.39%-72K
Gain on sale of security	136.12%536K	-87.21%132K	82.69%-228K	136.85%384K	257.96%248K	-772.94%-1.48M	953.06%1.03M	-422.62%-1.32M	-8,583.33%-1.04M	-3,825.00%-157K
Other non- operating income (expenses)	----	----	----	655.10%1.11M	958.82%900K	----	----	----	--147K	100.73%85K
Income before tax	22.38%-35.12M	53.09%-3.64M	59.02%-3.97M	64.24%-5.22M	-68.81%-22.29M	4.71%-45.24M	26.39%-7.76M	-0.70%-9.68M	-67.40%-14.6M	29.01%-13.2M
Income tax
Net income	22.38%-35.12M	53.09%-3.64M	59.02%-3.97M	64.24%-5.22M	-68.81%-22.29M	4.71%-45.24M	26.39%-7.76M	-0.70%-9.68M	-67.40%-14.6M	29.01%-13.2M
Net income continuous Operations	22.38%-35.12M	53.09%-3.64M	59.02%-3.97M	64.24%-5.22M	-68.81%-22.29M	4.71%-45.24M	26.39%-7.76M	-0.70%-9.68M	-67.40%-14.6M	29.01%-13.2M
Minority interest income
Net income attributable to the parent company	22.38%-35.12M	53.09%-3.64M	59.02%-3.97M	64.24%-5.22M	-68.81%-22.29M	4.71%-45.24M	26.39%-7.76M	-0.70%-9.68M	-67.40%-14.6M	29.01%-13.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	22.38%-35.12M	53.09%-3.64M	59.02%-3.97M	64.24%-5.22M	-68.81%-22.29M	13.04%-45.24M	26.39%-7.76M	11.47%-9.68M	-34.40%-14.6M	32.93%-13.2M
Basic earnings per share	24.42%-1.3	55.17%-0.13	59.46%-0.15	66.07%-0.19	-68.00%-0.84	59.43%-1.72	27.50%-0.29	47.14%-0.37	-20.96%-0.56	70.38%-0.5
Diluted earnings per share	24.42%-1.3	55.17%-0.13	59.46%-0.15	66.07%-0.19	-68.00%-0.84	59.43%-1.72	27.50%-0.29	47.14%-0.37	-20.96%-0.56	70.38%-0.5
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall